Ali Aldaoud

1.8k total citations
32 papers, 1.2k citations indexed

About

Ali Aldaoud is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Ali Aldaoud has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 16 papers in Genetics and 12 papers in Oncology. Recurrent topics in Ali Aldaoud's work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Advanced Breast Cancer Therapies (6 papers). Ali Aldaoud is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Advanced Breast Cancer Therapies (6 papers). Ali Aldaoud collaborates with scholars based in Germany, France and Spain. Ali Aldaoud's co-authors include Martin Dreyling, Wolfgang Hiddemann, Michael Unterhalt, Wolfgang Knauf, Hartmut Eimermacher, Ulrich Dührsen, Bernd Metzner, Raoul Herbrecht, Eva Hoster and K Merkle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

Ali Aldaoud

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Aldaoud Germany 14 945 678 574 194 183 32 1.2k
Riikka Räty Finland 18 883 0.9× 484 0.7× 731 1.3× 187 1.0× 92 0.5× 46 1.3k
Celeste Bello United States 13 808 0.9× 640 0.9× 544 0.9× 98 0.5× 247 1.3× 63 1.3k
Ulrich von Grünhagen Germany 6 1.2k 1.3× 789 1.2× 849 1.5× 129 0.7× 151 0.8× 10 1.4k
Alina S. Gerrie Canada 18 800 0.8× 422 0.6× 465 0.8× 157 0.8× 118 0.6× 110 1.1k
Toby A. Eyre United Kingdom 22 1.0k 1.1× 714 1.1× 594 1.0× 124 0.6× 178 1.0× 147 1.4k
Dorothea Kofahl-Krause Germany 10 1.5k 1.5× 921 1.4× 984 1.7× 156 0.8× 164 0.9× 15 1.6k
Astrid Franke Germany 13 641 0.7× 392 0.6× 403 0.7× 154 0.8× 111 0.6× 28 1.0k
Juergen Barth Germany 10 1.3k 1.4× 784 1.2× 913 1.6× 120 0.6× 146 0.8× 17 1.4k
J. M. Vose United States 15 801 0.8× 289 0.4× 596 1.0× 115 0.6× 148 0.8× 34 1.2k
Sophie Lefort France 6 994 1.1× 352 0.5× 698 1.2× 97 0.5× 167 0.9× 10 1.3k

Countries citing papers authored by Ali Aldaoud

Since Specialization
Citations

This map shows the geographic impact of Ali Aldaoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Aldaoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Aldaoud more than expected).

Fields of papers citing papers by Ali Aldaoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Aldaoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Aldaoud. The network helps show where Ali Aldaoud may publish in the future.

Co-authorship network of co-authors of Ali Aldaoud

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Aldaoud. A scholar is included among the top collaborators of Ali Aldaoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Aldaoud. Ali Aldaoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tresckow, Julia von, Sandra Robrecht, Ali Aldaoud, et al.. (2023). Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group. Annals of Hematology. 102(11). 3083–3090. 4 indexed citations
2.
3.
Kubasch, Anne Sophie, Georg‐Nikolaus Franke, Ali Aldaoud, et al.. (2020). Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma. Frontiers in Oncology. 10. 219–219. 3 indexed citations
4.
5.
6.
Reichart, Alexander, Claudia Pauligk, Rudolf Schlag, et al.. (2018). Quality of life (QoL) in patients with metastatic pancreatic cancer receiving first-line Nab-paclitaxel/gemcitabine chemotherapy: Results of the large QoL study AIO-QoliXane/PARAGON. Annals of Oncology. 29. viii252–viii252. 1 indexed citations
7.
Knauf, Wolfgang, Wolfgang Abenhardt, Ali Aldaoud, et al.. (2014). Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN). Oncology Research and Treatment. 37(11). 635–644. 9 indexed citations
8.
Binder, Claudia R., Marita Ziepert, Michael Pfreundschuh, et al.. (2013). CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial. Annals of Hematology. 92(11). 1521–1528. 19 indexed citations
9.
10.
Ernst, Jochen, Susanne Kuhnt, Andreas Schwarzer, et al.. (2010). The desire for shared decision making among patients with solid and hematological cancer. Psycho-Oncology. 20(2). 186–193. 42 indexed citations
11.
Ernst, Jochen, Elmar Brähler, Ali Aldaoud, et al.. (2009). Desired and perceived participation in medical decision-making in patients with haemato-oncological diseases. Leukemia Research. 34(3). 390–392. 15 indexed citations
12.
Ernst, Jochen, Andreas Schwarzer, Ali Aldaoud, et al.. (2009). Die Rolle der Angehörigen bei medizinischen Entscheidungen – Empirische Befunde zu hämatoonkologischen Erkrankungen. Das Gesundheitswesen. 71(08/09). 469–475.
13.
Link, Hartmut, C.-H. Köhne, Michael Stahl, et al.. (2008). Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial. British Journal of Cancer. 100(1). 44–49. 55 indexed citations
14.
15.
16.
17.
Knauf, Wolfgang, Ali Aldaoud, Raoul Herbrecht, et al.. (2007). Bendamustine Versus Chlorambucil in Treatment-Naive Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results of an International Phase III Study.. Blood. 110(11). 2043–2043. 33 indexed citations
18.
19.
Knauf, Wolfgang, Toshko Lissitchkov, Raoul Herbrecht, et al.. (2004). Bendamustine Versus Chlorambucil in Treatment-Naive B-CLL Patients.. Blood. 104(11). 4817–4817. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riikka Räty Breakdown of academic impact, for papers by Celeste Bello Breakdown of academic impact, for papers by Ulrich von Grünhagen Breakdown of academic impact, for papers by Alina S. Gerrie Breakdown of academic impact, for papers by Toby A. Eyre Breakdown of academic impact, for papers by Dorothea Kofahl-Krause Breakdown of academic impact, for papers by Astrid Franke Breakdown of academic impact, for papers by Juergen Barth Breakdown of academic impact, for papers by J. M. Vose Breakdown of academic impact, for papers by Sophie Lefort
Rankless by CCL
2026